Mitech
엠아이텍 · 179290
Health Care Medical Devices · KOSDAQ
Market cap US$113.7M (₩157B)
Overview
Mitech makes non-vascular stents, small mesh tubes inserted into digestive-tract passages such as the esophagus or colon to keep them open, and supplies them to hospitals and clinicians in South Korea and overseas.
The company, listed on KOSDAQ (South Korea's tech and small-cap exchange), also distributes gastrointestinal endoscopy equipment domestically. Its core stent business spans both malignant and benign conditions, as well as veterinary use, and the company holds the updated European medical-device regulatory certification (CE MDR) that is required to access EU and CE-aligned markets.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$33.6M
- FY2024US$39M
- FY2025US$48.7M
Operating profit
- FY2023US$10.2M
- FY2024US$12.7M
- FY2025US$15M
Net income
- FY2023US$9.3M
- FY2024US$13.3M
- FY2025US$0
Key ratios (FY2025)
Why it matters
Mitech claims to have been the first in South Korea to develop a non-vascular stent, and it conducts new product development in collaboration with major domestic hospitals and government-funded research programs.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?